ZURA
NASDAQ · Biotechnology
Zura Bio Ltd
$5.95
+0.27 (+4.75%)
Financial Highlights (FY 2025)
Revenue
178.15M
Net Income
4.79M
Gross Margin
58.6%
Profit Margin
2.7%
Rev Growth
+24.5%
D/E Ratio
0.26
Revenue & Net Income
Margin Trends
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Gross Margin | 58.6% | 58.6% | 58.6% |
| Operating Margin | 3.6% | 4.0% | 3.9% |
| Profit Margin | 2.7% | 2.9% | 3.3% |
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 178.15M | 170.40M | 174.38M |
| Gross Profit | 104.39M | 99.85M | 102.18M |
| Operating Income | 6.38M | 6.82M | 6.77M |
| Net Income | 4.79M | 4.86M | 5.73M |
| Gross Margin | 58.6% | 58.6% | 58.6% |
| Operating Margin | 3.6% | 4.0% | 3.9% |
| Profit Margin | 2.7% | 2.9% | 3.3% |
| Rev Growth | +24.5% | +6.4% | +20.2% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 64.32M | 77.12M | 80.74M |
| Total Equity | 250.84M | 225.49M | 225.65M |
| D/E Ratio | 0.26 | 0.34 | 0.36 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 8.96M | 8.92M | 9.38M |
| Free Cash Flow | 5.34M | 5.40M | 5.82M |